The authors have made substantial changes based on earlier comments.
MINOR: There is still only a partial risk of bias assessment - i.e. only 3 components of the Cochrane RoB tool is being
assessed - domains “Incomplete outcome data” and “Selective reporting” have been assessed - why not - in the
response, it is mentioned that only the first 3 are being assessed, why are't the other 2 domains of relevant?

Also Table 3 'Quality of Trial' column should be re-labelled as 'Risk of Bias'